Check the time stamp on this data. Updated AI-Generated Signals for Siga Technologies Inc. (SIGA) available here: SIGA. Type ...

Siga Technologies Inc. (SIGA) closed the most recent trading day at $6.35, moving +0.32% from the previous trading session. This move lagged the S&P 500's daily gain of 1.83%. Elsewhere, the Dow saw ...

The most recent trading session ended with Siga Technologies Inc. (SIGA) standing at $6.23, reflecting a -0.24% shift from the previouse trading day's closing. This move lagged the S&P 500's daily ...

Japan approves SIGA's TEPOXX, the first antiviral for orthopoxviruses, for smallpox, mpox, cowpox, and vaccine-related complications. Approval is based on 15 clinical trials and pivotal animal ...

(RTTNews) - SIGA Technologies, Inc. (SIGA), Thursday announced that its tecovirimat 200 mg capsules, traded as TEPOXX, has secured regulatory approval in Japan for the treatment of smallpox ...

Siga Technologies (SIGA)’ antiviral treatment Tepoxx, has received regulatory approval in Japan for the treatment of smallpox, mpox, cowpox, as well as complications following smallpox ...

Taking place at Farnborough International Exhibition Centre on 4th – 6th February 2025, it is the UK’s largest annual industrial showcase for new technology in machinery, production equipment, ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

This country research report on Vietnam Stool Secretory Immunoglobulin a [SIgA] Market offers comprehensive insights into the market landscape, customer intelligence, and competitive strategies in the ...

On Thursday, the Japan Ministry of Health, Labour and Welfare approved SIGA Technologies (NASDAQ:SIGA) antiviral treatment TEPOXX (tecovirimat 200 mg capsules) for smallpox, mpox, cowpox ...